Sign up for our newsletter
Region / Americas

Americas

How Pfizer is targeting Covid with new sustainability bond

How Pfizer is targeting Covid with new sustainability bond

The US drugs giant will use proceeds from its second sustainability bond issue to tackle the pandemic, including in emerging markets. ESG head Chris Gray seeks to dispel scepticism by explaining the deal's rationale, while treasurer Brian McMahon discusses the $1bn bond’s pricing.

White Papers

Why capitalism should have listened to the King of Bhutan

Why capitalism should have listened to the King of Bhutan

The idea of incorporating gross national happiness into mainstream economic thought has long been a subject reserved for debating societies and 'lefty' thinkers. As politicians are cornered into taking immediate action on climate change, capitalism is in for a big surprise.

Are the SDGs fit for purpose?

Are the SDGs fit for purpose?

Thousands of companies say they report against or otherwise align themselves with the UN’s Sustainable Development Goals. But where are these high-level targets failing and what more can businesses and policymakers do to help achieve them?

How Australia’s Aware Super is tackling modern slavery

How Australia’s Aware Super is tackling modern slavery

The A$150bn pension fund is using its financial heft to address modern slavery and has developed a risk-assessment tool to support its reporting requirements. But while some asset managers have shown overwhelming support, others are still burying their heads in the sand.

Japan’s young sustainable loan market gets healthcare booster

Japan’s young sustainable loan market gets healthcare booster

Medical device maker Nipro has become a rare Japanese issuer of a sustainability-linked loan, and the first from the healthcare sector. Disclosed details are limited, but it aims to use the proceeds to help address Covid-19 issues and generally improve public health both domestically and overseas. 

Shareholder resolutions surge, but impact in doubt

Shareholder resolutions surge, but impact in doubt

The year to date has seen record-breaking support for shareholder resolutions, with asset managers such as BlackRock and Vanguard stepping up their stewardship. However, a lack of data on the real-world impact means the jury is still out on their efficacy.

50 resultsShow more
By clicking Sign Up, you agree with New Statesman Media Group Ltd (publisher of Capital Monitor) GDPR, Privacy Policy and Terms and Conditions.

Hot Topics